Julia Fedorova

Julia Fedorova

Auto-generated profile, based on publicly available information

Julia Fedorova

University of Central Florida College of Medicine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2023 in Aging Cell
Verified
Journal Article
Open access
MFMohammad Kasim Fatmi
Mohammad Kasim Fatmi
DRDi Ren
Di Ren
JFJulia Fedorova
Julia Fedorova
LZLinda Ines Zoungrana
Linda Ines Zoungrana
HWHao Wang
Hao Wang
Ji LiJi Li
Ji Li
Ischemic heart disease (IHD) is the leading cause of death, with age range being the primary factor for development. The mechanisms by which aging increases vulnerability to ischemic insult are not well understood. We aim to use single‐cell RNA sequencing to discover transcriptional differences in various cell types between aged and young mice, which may contribute to aged‐related vulnerability to ischemic insult. Utilizing 10× Genomics Single‐Cell RNA sequencing, we were able to complete bioinformatic analysis to identity novel differential gene expression. During the analysis of our collected samples, we detected Pyruvate Dehydrogenase Kinase 4 (Pdk4) expression to be remarkably differentially expressed. Particularly in cardiomyocyte cell populations, Pdk4 was found to be significantly upregulated in the young mouse population compared to the aged mice under ischemic/reperfusion conditions. Pdk4 is responsible for inhibiting the enzyme pyruvate dehydrogenase, resulting in the regulation of glucose metabolism. Due to decreased Pdk4 expression in aged cardiomyocytes, there may be an increased reliance on glucose oxidization for energy. Through biochemical metabolomics analysis, it was observed that there is a greater abundance of pyruvate in young hearts in contrast to their aged counterparts, indicating less glycolytic activity. We believe that Pdk4 response provides valuable insight towards mechanisms that allow for the young heart to handle ischemic insult stress more effectively than the aged heart.

1 January 2021 in Redox Biology
Verified
Journal Article
Open access
DRDi Ren
Di Ren
ZHZhibin He
Zhibin He
JFJulia Fedorova
Julia Fedorova
Jingwen ZhangJingwen Zhang
Jingwen Zhang
EWElizabeth Wood
Elizabeth Wood
Ji LiJi Li
Ji Li
Sestrin2 (Sesn2) is a stress-inducible protein that declines with aging in the heart. We reported that rescue Sesn2 levels in aged mouse hearts through gene therapy improves the resistance of aged hearts to ischemia and reperfusion (I/R) insults. We hypothesize that Sesn2 as a scaffold protein maintains mitochondrial integrity to protect heart from ischemic injury during I/R. Young C57BL/6 J (3-6 months), aged C57BL/6 J (24-26 months), and young Sesn2 KO (3-6 months, C57BL/6 J background) mice were subjected to in vivo regional ischemia and reperfusion. The left ventricle was collected for transcriptomics, proteomics and metabolomics analysis. The results demonstrated that Sesn2 deficiency leads to aging-like cardiac diastolic dysfunction and intolerance to ischemia reperfusion stress. Seahorse analysis demonstrated that Sesn2 deficiency in aged and young Sesn2 KO versus young hearts lead to impaired mitochondrial respiration rate with defects in Complex I and Complex II activity. The Sesn2 targeted proteomics analysis revealed that Sesn2 plays a critical role in maintaining mitochondrial functional integrity through modulating mitochondria biosynthesis and assembling of oxidative phosphorylation (OXPHOS) complexes. The RNA-Seq data showed that alterations in the expression of mitochondrial compositional and functional genes and substrate metabolism related genes in young Sesn2 KO and aged versus young hearts. Further immunofluorescence and immunoprecipitation analysis demonstrated that Sesn2 is translocated into mitochondria and interacts with OXPHOS components to maintain mitochondrial integrity in response to I/R stress. Biochemical analysis revealed that Sesn2 is associated with citrate cycle components to modulate pyruvate dehydrogenase and isocitrate dehydrogenase activities during I/R stress. Thus, Sesn2 serves as a scaffold protein interacting with OXPHOS components to maintain mitochondrial integrity under I/R stress. Age-related downregulation of cardiac Sesn2 fragilizes mitochondrial functional integrity in response to ischemic stress.

19 February 2025 in Aesthetic Surgery Journal
Verified
Journal Article
Open access
DSDanny Soares
Danny Soares
JFJulia Fedorova
Julia Fedorova
YZYu Zhang
Yu Zhang
ACAkash Chandawarkar
Akash Chandawarkar
ABAlexis Bowhay
Alexis Bowhay
DFDavid K Funt
David K Funt
Background: Despite the recently increased incidence and improved awareness of filler-induced ischemic injuries, the arterioembolic behavior of filler products has not been well described. Objectives: To evaluate the embolic behavior of varying dilutions of calcium hydroxylapatite-carboxymethylcellulose (CaHA-CMC) gel mixtures within an artificial macrovascular perfusion model of the proximal facial artery with correlation against published instances of ischemic injuries in the literature. Methods: CaHA-CMC gel mixtures were assessed through the Pulsatile Unit for the Laboratory Simulation of Arterioembolic Restrictions (PULSAR) system at different flow rates. The occlusive behavior, embolic particle size distributions, and morphological attributes were evaluated through direct photographic and videographic captures followed by digital image processing. The PubMed database was systematically queried for all published instances of CaHA-CMC-associated ischemic injuries. Results: Undiluted CaHA-CMC demonstrated highly cohesive behavior upon PULSAR inoculation, with a tendency toward proximal occlusion. Gel fragmentation resulted in a polydisperse embolic mixture averaging 0.151 ± 0.61 mm² (interquartile range: 0.006-0.022 mm²) in size. Product dilution had a profound effect on embolic behavior, with a significant reduction in average particle size (0.018 ± 0.03 mm²; interquartile range: 0.005-0.018 mm²; P < .0001) and complete elimination of proximally occlusive capacity for hyperdiluted mixtures compared with undiluted product (P = .002). Confirmed hyperdiluted CaHA-CMC-associated ischemic injuries represented only 3% of published reports, with a predominantly self-limited clinical course. Conclusions: Embolized CaHA-CMC gels produce polydisperse particle mixtures with a preponderance of microparticles. Hyperdilution profoundly reduced the proximally occlusive potential of the product.

28 May 2025 in The Cleft Palate Craniofacial Journal
Verified
Journal Article
Closed access
JFJulia Fedorova
Julia Fedorova
HBHannah Brown
Hannah Brown
PRPedro Fuenmayor Rojas
Pedro Fuenmayor Rojas
YGYeraldi Geronimo
Yeraldi Geronimo
ABAngelo Leto Barone
Angelo Leto Barone
BKBrian Kellogg
Brian Kellogg
An 8-year-old female presented with severe hypernasality and suspected velopharyngeal dysfunction (VPD). Physical examination demonstrated a hypoplastic hemi-velum, tongue atrophy, and deviated uvula. Nasopharyngoscopy demonstrated a significant, asymmetric velopharyngeal gap with adynamic hemi-velum and no lateral pharyngeal wall movement. Given the patient's focal neurologic findings, a magnetic resonance imaging was obtained for further evaluation. Magnetic resonance imaging findings were consistent with Chiari malformation type 1. This case illustrates an unusual presentation of VPD likely secondary to cranial nerve compression and resulting atrophy. Chiari malformation should be considered in the differential diagnosis of noncleft VPD, especially in the setting of palatal asymmetries or other focal neurologic deficits.